Outpatient Treatment of Patients with Pulmonary Embolism

 

 Buy Article Permissions and Reprints

ABSTRACT

Very few treatment studies have included patients with pulmonary embolism (PE) but there have been many enrolling patients with deep vein thrombosis (DVT). Should treatment for PE be different from treatment for DVT? Post-mortem and clinical studies have shown a strong association between PE and the presence of venous thrombosis in the lower limbs but some recent data suggest that certain clinical factors will predict patients at higher risk of death from PE. Unfortunately, it is not clear that identifying patients as high risk will affect outcome.

Two large studies recently compared treatment with unfractionated heparin to treatment with low-molecular-weight heparin in patients with PE. Combining the two studies, the rates of recurrent DVT or PE were 2.9% (13/442) in the low-molecular-weight heparin group and 3.2% (14/441) in the unfractionated heparin group, and major hemorrhage occurred in fewer than 3% of patients. The feasibility of providing outpatient care to many patients presenting to tertiary care hospitals with acute PE has become evident. In our institutions, the data suggest about 50% of patients with PE could be treated as outpatients. Until further knowledge is available, it is not unreasonable to perform echocardiography and cardiac troponin T on patients with PE if they are not completely stable or if concern over concomitant cardiopulmonary disease exists. If they meet criteria demonstrated to result in early death, it is of course reasonable not to treat such patients on a solely outpatient basis. Evidence is accumulating that patients with PE as their initial symptom complex of their venous thromboembolic disease have a worse prognosis, specifically, higher risk of recurrence and higher risk of death, but there are no data to suggest outpatient therapy will affect their prognosis. Low-molecular-weight heparin or intravenous unfractionated heparin, followed by oral anticoagulant therapy, provide adequate therapy in most patients with PE, and many can be treated as outpatients.

REFERENCES

• 1 Anderson Jr A F, Wheeler H B, Goldberg R J. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester Study.  Arch Intern Med . 1991;  151 933-938
  CrossrefPubMedGoogle Scholar
• 2 Alpert J S, Smith R, Carlson C J, Ockene I S, Dexter L, Dalen J E. Mortality in patients treated for pulmonary embolism.  JAMA . 1976;  236 1477-1480
  CrossrefPubMedGoogle Scholar
• 3 Goldhaber S Z, Visani L, De Rosa M, ICOPER. Acute pulmonary embolism: clinical outcomes in the international cooperative pulmonary embolism registry (ICOPER).  Lancet . 1999;  353 1386-1389
  CrossrefPubMedGoogle Scholar
• 4 Carson J L, Kelley M A, Duff A. Clinical course of pulmonary embolism.  N Engl J Med . 1992;  326 1240-1245
  CrossrefPubMedGoogle Scholar
• 5 Wicki J, Perrier A, Perneger T V, Bounameaux H, Junod A F. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score.  Thromb Haemost . 2000;  84 548-552
  Article in Thieme ConnectPubMedGoogle Scholar
• 6 Columbus Investigators, ten Cate W J. Low molecular weight heparin in the treatment of patients with venous thromboembolism.  N Engl J Med . 1997;  337 657-662
  CrossrefPubMedGoogle Scholar
• 7 Simonneau G, Sors H, Charbonnier B. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism.  N Engl J Med . 1997;  337 663-669
  CrossrefPubMedGoogle Scholar
• 8 Huisman M V, Büller H R, ten Cate W J. Unexpected high prevalence of silent pulmonary embolism in patients with deep vein thrombosis.  Chest . 1989;  95 498-502
  CrossrefPubMedGoogle Scholar
• 9 Meignan M, Rosso J, Gauthier H. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep vein thrombosis.  Arch Intern Med . 2000;  160 159-164
  CrossrefPubMedGoogle Scholar
• 10 Moser K M, Fedullo P F, Littlejohn J K, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis.  JAMA . 1994;  271 223-225
  CrossrefPubMedGoogle Scholar
• 11 Monreal M, Ruiz J, Olazabal A, Arias A, Roca J. Deep venous thrombosis and the risk of pulmonary embolism.  Chest . 1992;  102 677-681
  CrossrefPubMedGoogle Scholar
• 12 Douketis J D, Kearon C, Bates S, Duku E K, Ginsberg J S. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism.  JAMA . 1998;  279 458-462
  CrossrefPubMedGoogle Scholar
• 13 Heit J, Silverstein M D, Mohr D N, Petterson T M, O'Fallon W M, Melton III M L. Predictors of survival after deep vein thrombosis and pulmonary embolism.  Arch Int Med . 1999;  159 445-453
  CrossrefPubMedGoogle Scholar
• 14 Eichinger S, Schoenauer V, Minar E, Schneider B, Kyrle P A. The risk of recurrent venous thromboembolism in patients with symptomatic pulmonary embolism.  Blood . 2001 Abstract;  96 2789
  PubMedGoogle Scholar
• 15 Kasper W, Konstantinides S, Geibel A. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism.  Heart . 1997;  77 346-349
  PubMedGoogle Scholar
• 16 Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism. One-year follow-up with echocardiography Doppler and five-year survival analysis.  Circulation . 1999;  99 1325-1330
  CrossrefPubMedGoogle Scholar
• 16a Giannitisis E, Mueller-Bardoff M, Kurowski V. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism.  Circulation . 2000;  102 211-217
  CrossrefPubMedGoogle Scholar
• 17 Gould M K, Dembitzer A D, Doyle R L, Hastie T J, Garber A M. Low-molecular-weight heparin compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.  Ann Intern Med . 1999;  130 800-809
  CrossrefPubMedGoogle Scholar
• 18 Koopman M MW, Prandoni P, Piovella F. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home.  N Engl J Med . 1996;  334 682-687
  CrossrefPubMedGoogle Scholar
• 19 Levine M, Gent M, Hirsh J. A comparison of heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis.  N Engl J Med . 1996;  334 677-681
  CrossrefPubMedGoogle Scholar
• 20 Wells P S, Kovacs M J, Bormanis J. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. A comparison of patient self-injection with homecare injection.  Arch Intern Med . 1998;  158 1809-1812
  CrossrefPubMedGoogle Scholar
• 21 Meyer G, Brenot F, Pacouret G. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute nonmassive pulmonary embolism: an open randomized pilot study.  Thromb Haemost . 1995;  74 1432-1435
  PubMedGoogle Scholar
• 22 Kovacs M J, Anderson D R, Morrow B, Gray L, Touchie D, Wells P S. Outpatient treatment of pulmonary embolism with dalteparin.  Thromb Haemost . 2000;  83 209-211
  PubMedGoogle Scholar
• 23 Hutten B A, Prins M H, Gent M, Ginsberg J, Tijssen J GP, Büller H R. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.  J Clin Onc . 2000;  18 3078-3083
  PubMedGoogle Scholar
• 24 Hull R D, Raskob G E, Pineo G F. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis.  N Engl J Med . 1992;  326 975-982
  CrossrefPubMedGoogle Scholar
• 25 Hull R D, Raskob G E, Brant R F. Low-molecular-weight heparin versus heparin in the treatment of patients with pulmonary embolism.  Arch Intern Med . 2000;  160 229-236
  CrossrefPubMedGoogle Scholar